Clinical Analysis of drug inTEraction between CatecHin and Ixazomib for patieNts with multiple myeloma
Not Applicable
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-UMIN000031235
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Using other anticancer drugs 2. Systemic surgery within 14 days 3. active infections 4. CNS involvement 5. uncontrolable cardiovascular disease 6. active HBV, HCV, or HIV 7. severe complications 8. difficulty in swallowing 9. mental diseases 10. allergic to study drugs 11. pregnant or Brest feeding 12. strong CYP1A2 inhibitor, strong CYP3A inhibitor, CYP3A inducer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PK parameters of Ixazomib
- Secondary Outcome Measures
Name Time Method